Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $12 | $12 | $13 | $12 |
| % Growth | -3% | -5.4% | 8.2% | – |
| Cost of Goods Sold | $9 | $10 | $9 | $12 |
| Gross Profit | $3 | $3 | $3 | -$0 |
| % Margin | 23.1% | 21.1% | 25.9% | -3.2% |
| R&D Expenses | $17 | $25 | $27 | $22 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $21 | $31 | $39 | $49 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $38 | $57 | $66 | $71 |
| Operating Income | -$35 | -$54 | -$63 | -$72 |
| % Margin | -301.8% | -448% | -492.5% | -607.4% |
| Other Income/Exp. Net | -$15 | -$7 | $0 | -$6 |
| Pre-Tax Income | -$50 | -$61 | -$63 | -$78 |
| Tax Expense | -$0 | $1 | -$0 | $0 |
| Net Income | -$50 | -$62 | -$62 | -$78 |
| % Margin | -427.8% | -511% | -490.1% | -659.5% |
| EPS | -2.15 | -4.94 | -7.61 | -12.59 |
| % Growth | 56.5% | 35.1% | 39.6% | – |
| EPS Diluted | -2.15 | -4.94 | -7.61 | -12.59 |
| Weighted Avg Shares Out | 23 | 12 | 8 | 6 |
| Weighted Avg Shares Out Dil | 23 | 12 | 8 | 6 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $0 |
| Interest Expense | $13 | $8 | $4 | $16 |
| Depreciation & Amortization | $3 | $3 | $3 | $3 |
| EBITDA | -$34 | -$50 | -$56 | -$60 |
| % Margin | -287% | -412.7% | -437.6% | -505.8% |